Literature DB >> 31729272

Impact of pain, fatigue and dyspnoea on occupational performance in people with advanced cancer: A longitudinal study.

Marc Sampedro Pilegaard1,2,3, Karen la Cour2, Åse Brandt1, Mario Lozano-Lozano4,5,6, Lisa Gregersen Oestergaard1,7,8.   

Abstract

Background: Pain, fatigue and dyspnoea are symptoms commonly experienced by people with advanced cancer, which may impact on their occupational performance. It is not known whether these symptoms impact their occupational performance over time.Objective: To examine correlation between pain, fatigue and dyspnoea and occupational performance and the impact of such symptoms on occupational performance over time in people with advanced cancer.Material and
Methods: A longitudinal study was conducted including 242 participants assessed at baseline and after six and 12 weeks. Spearman's rank-order test and mixed linear models were performed.
Results: The correlation between pain, fatigue and dyspnoea and occupational performance at baseline spanned from trivial to moderate (Spearman's rho: -0.004 to 0.34). Only pain had a statistically significant impact on activities of daily living (ADL) motor ability over time (p = 0.01). Participants with no pain problems had the largest decrease in ADL motor ability (-0.24 logits (95%-CI: -0.37 to -0.12)), but the observed decrease was not clinically relevant (≥-0.30).
Conclusion: Pain, fatigue and dyspnoea did not seem to highly correlate with occupational performance or impact occupational performance over time of people with advanced cancer.

Entities:  

Keywords:  Cancer; longitudinal study; occupational performance; occupational therapy

Mesh:

Year:  2019        PMID: 31729272     DOI: 10.1080/11038128.2019.1690042

Source DB:  PubMed          Journal:  Scand J Occup Ther        ISSN: 1103-8128            Impact factor:   2.611


  1 in total

1.  Stepped-care cognitive behaviour therapy program for treating cancer-related fatigue: protocol for a feasibility study.

Authors:  Lauren K Williams; Maria Ftanou; Elizabeth J Pearson
Journal:  Pilot Feasibility Stud       Date:  2022-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.